Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis

This publication has 14 references indexed in Scilit:

• Prevention of Venous Thromboembolism
  Chest, 2001
• The Pre-, Peri-, and Postsurgical Activation of Coagulation and the Thromboembolic Risk for Different Risk Groups
  Thrombosis Research, 2000
• Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin Extended Out-of-Hospital vs In-Hospital Warfarin/Out-of-Hospital Placebo in Hip Arthroplasty Patients
  Archives of internal medicine (1960), 2000
• Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data
  Medicine, 1999
• Efficacy and Safety of Prolonged Thromboprophylaxis with a Low Molecular Weight Heparin (Dalteparin) after Total Hip Arthroplasty— The Danish Prolonged Prophylaxis (DaPP) Study
  Thrombosis Research, 1998
• Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis against Venous Thromboembolism after Total Hip Replacement
  New England Journal of Medicine, 1996
• Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo
  The Lancet, 1996
• Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery
  Thrombosis Research, 1995
• Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 Xal units in 2070 patients
  British Journal of Surgery, 1995
• Heparin with and without graded compression stockings in the prevention of thromboembolic complications of major abdominal surgery: A randomized trial
  British Journal of Surgery, 1985